You are here

AbbVie

AbbVie’s migraine drug meets main goal in head-to-head study with topiramate

Investing.com

Wed, 06/18/25 - 11:20 am

clinical trials

AbbVie (ABBV) Faces Setback with Leukemia Drug Trial

Guru Focus

Mon, 06/16/25 - 06:30 pm

clinical trials

myelodysplastic syndrome

EHA 2025: Genmab and AbbVie’s Epkinly outpaces BiTE rivals in r/r DLBCL trial

Clinical Trials Arena

Mon, 06/16/25 - 10:53 am

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons

Clinical Trials Arena

Tue, 06/3/25 - 11:03 pm

non-small cell lung cancer

telisotuzumab adizutecan

AbbVie’s ADC win shows how pharma can break through in solid tumors

Pharma Voice

Fri, 05/30/25 - 11:09 am

antibody-drug conjugates

AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide

Fierce Pharma

Tue, 05/27/25 - 10:19 pm

Allergan Aesthetics

Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change

Pharma Voice

Tue, 05/27/25 - 11:10 am

pharma industry

AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis

Fierce Pharma

Wed, 05/14/25 - 10:50 pm

advanced non-squamous non-small cell lung cancer

AbbVie pays ADARx $335M cash for next-gen siRNA options

Fierce Biotech

Wed, 05/14/25 - 11:20 am

ADARx Pharmaceuticals

AbbVie’s Skyrizi leads pharma TV ad rankings for April

Medical Marketing and Media

Thu, 05/8/25 - 10:59 am

DTC advertising

AbbVie makes its tariffs-driven investment play

Pharmaphorum

Mon, 04/28/25 - 09:31 am

drug manufacturing

AbbVie hikes its outlook on the back of two powerhouse drugs

Investors Business Daily

Fri, 04/25/25 - 11:23 am

AbbVie files fast-acting Botox successor in US

Pharmaphorum

Fri, 04/25/25 - 10:41 am

Five Biggest Drug Face-Offs in Pharma History

BioSpace

Wed, 04/9/25 - 11:38 am

Bristol Myers Squibb

Rinvoq cleared for giant cell arteritis in EU, ahead of US

Pharmaphorum

Tue, 04/8/25 - 11:18 am

giant cell arteritis

Boosted by March Madness, Tremfya takes the lead in TV pharma ad rankings

Medical Marketing and Media

Mon, 04/7/25 - 11:13 am

DTC advertising

The top 10 pharma R&D budgets for 2024

Fierce Biotech

Fri, 04/4/25 - 11:30 am

Bristol Myers Squibb

AbbVie takes Genmab to court, accusing partner of being 'willfully blind' to ADC trade secret theft

Fierce Biotech

Tue, 03/25/25 - 10:25 am

AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer

Clinical Trials Arena

Mon, 03/17/25 - 10:58 am

platinum-resistant ovarian cancer

clinical trials

As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first year as CEO

Fierce Pharma

Tue, 03/11/25 - 07:03 pm

executive compensation

Pages